Austin Retina Associates
Robert Wong is a highly experienced vitreoretinal surgeon and partner at Austin Retina Associates since June 2009, specializing in the management and treatment of various vitreoretinal conditions. In addition to clinical practice, Robert serves as the primary investigator for numerous clinical research trials. Currently, Robert holds the position of Director at Alcolear Inc., where the focus is on developing the US sales and marketing strategy for BuzzClear, an innovative alcohol drinking supplement. As a Clinical Educator at the Dell Medical School at The University of Texas at Austin since August 2016, Robert contributes to medical education. Robert began a healthcare technology and policy blog in October 2015 while previously working at 36th and Hamilton from 2015 to 2018. Educational qualifications include an MD from the University of Pennsylvania School of Medicine, residency at the Scheie Eye Institute, and a BS from Duke University.
This person is not in any teams
Austin Retina Associates
Austin Retina Associates has been serving the citizens of Austin and surrounding communities since 1978. It is the largest retinal specialty group in Central Texas. Each of the highly respected retina physicians at Austin Retina Associates is a board-certified, licensed ophthalmologist and fellowship-trained retinal surgeon who is an expert in managing diseases involving the retina, vitreous and macula. The Austin Retina specialists concentrate on diabetic eye disease, retinal detachment, macular edema, epiretinal membrane, floaters, retinal surgery and more. Between them is over 100 years of combined medical knowledge and professional experience in providing patients with the very best vitreoretinal care available. ARA continues to remain at the forefront of retinal specialty practices by utilizing cutting-edge diagnostic equipment while offering state-of-the-art surgical procedures and pharmaceutical treatment regimens. ARA collaborates with referring ophthalmologists, optometrists, primary care physicians and specialists to comprehensively treat vitreoretinal disease. Additionally, Austin Retina Associates is nationally recognized for its participation in ground-breaking, pivotal clinical trials for 25 years, which has allowed us to offer our patients the opportunity to receive novel procedures and therapies through enrollment in research studies.